In relation to therapy, overexpression of miR-155 seems to increase the chemoresistance of tumor cells to cisplatin, potentially by downregulating forkhead box O3 (FOXO3), a tumor suppressor transcription factor which could possibly be exploited for the treatment of drug-resistant CRC [126]. Here, FOXO3 is linked to neoplasm.